CFTR and cystic fibrosis: CF subjects receiving CFTR modulator therapy showed partial restoration of CFTR function in the platelets, suggesting primary defects in CF platelets as an upstream trigger for neutrophilic inflammation and NET formation in CF lung disease [65].